Tight junctions in brain barriers during central nervous system inflammation.

Homeostasis within the central nervous system (CNS) is a prerequisite to elicit proper neuronal function. The CNS is tightly sealed from the changeable milieu of the blood stream by the blood-brain barrier (BBB) and the blood-cerebrospinal fluid (CSF) barrier (BCSFB). Whereas the BBB is established by specialized endothelial cells of CNS microvessels, the BCSFB is formed by the epithelial cells of the choroid plexus. Both constitute physical barriers by a complex network of tight junctions (TJs) between adjacent cells. During many CNS inflammatory disorders, such as multiple sclerosis, human immunodeficiency virus infection, or Alzheimer's disease, production of pro-inflammatory cytokines, matrix metalloproteases, and reactive oxygen species are responsible for alterations of CNS barriers. Barrier dysfunction can contribute to neurological disorders in a passive way by vascular leakage of blood-borne molecules into the CNS and in an active way by guiding the migration of inflammatory cells into the CNS. Both ways may directly be linked to alterations in molecular composition, function, and dynamics of the TJ proteins. This review summarizes current knowledge on the cellular and molecular aspects of the functional and dysfunctional TJ complexes at the BBB and the BCSFB, with a particular emphasis on CNS inflammation and the role of reactive oxygen species.

[1]  L. Mitchell,et al.  Claudins: control of barrier function and regulation in response to oxidant stress. , 2011, Antioxidants & redox signaling.

[2]  Bernhard Hennig,et al.  Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinases. , 2011, Antioxidants & redox signaling.

[3]  I. Blasig,et al.  Occludin protein family: oxidative stress and reducing conditions. , 2011, Antioxidants & redox signaling.

[4]  G. Bazzoni Pathobiology of junctional adhesion molecules. , 2011, Antioxidants & redox signaling.

[5]  D. Antonetti,et al.  Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species. , 2011, Antioxidants & redox signaling.

[6]  Mónica Díaz-Coránguez,et al.  ZO proteins and redox-dependent processes. , 2011, Antioxidants & redox signaling.

[7]  I. Ferrer,et al.  Aβ accumulation in choroid plexus is associated with mitochondrial-induced apoptosis , 2010, Neurobiology of Aging.

[8]  E. V. Van Bockstaele,et al.  HIV-1 gp120-Induced Injury to the Blood-Brain Barrier: Role of Metalloproteinases 2 and 9 and Relationship to Oxidative Stress , 2010, Journal of neuropathology and experimental neurology.

[9]  Hyoung-Gon Lee,et al.  Antioxidant approaches for the treatment of Alzheimer’s disease , 2010, Expert review of neurotherapeutics.

[10]  S. Milatz,et al.  Claudin-2, a component of the tight junction, forms a paracellular water channel , 2010, Journal of Cell Science.

[11]  E. V. Bockstaele,et al.  Blood–brain barrier abnormalities caused by exposure to HIV-1 gp120 — Protection by gene delivery of antioxidant enzymes , 2010, Neurobiology of Disease.

[12]  H. Galla,et al.  Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions , 2010, Brain Research.

[13]  A. Fujimura,et al.  Claudin-2–deficient mice are defective in the leaky and cation-selective paracellular permeability properties of renal proximal tubules , 2010, Proceedings of the National Academy of Sciences.

[14]  B. Becher,et al.  Cellular mechanisms of IL‐17‐induced blood‐brain barrier disruption , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  K. Hirata,et al.  Interaction of endothelial cell‐selective adhesion molecule and MAGI‐1 promotes mature cell–cell adhesion via activation of RhoA , 2010, Genes to cells : devoted to molecular & cellular mechanisms.

[16]  K. Plate,et al.  Differentiation of the brain vasculature: the answer came blowing by the Wnt , 2010, Journal of angiogenesis research.

[17]  B. Engelhardt,et al.  The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction , 2009, Seminars in Immunopathology.

[18]  D. Antonetti,et al.  Occludin Phosphorylation and Ubiquitination Regulate Tight Junction Trafficking and Vascular Endothelial Growth Factor-induced Permeability* , 2009, The Journal of Biological Chemistry.

[19]  J. Ghersi-Egea,et al.  The Role of the Choroid Plexus in Neutrophil Invasion after Traumatic Brain Injury , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  B. Engelhardt,et al.  C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE , 2009, Nature Immunology.

[21]  I. Romero,et al.  Amyloid-β-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation , 2009, Journal of cellular and molecular medicine.

[22]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.

[23]  M. Mohsenzadegan,et al.  Antioxidant therapy in multiple sclerosis , 2009, Immunopharmacology and immunotoxicology.

[24]  Elisabetta Dejana,et al.  The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. , 2009, Developmental cell.

[25]  L. Nencioni,et al.  GSH and analogs in antiviral therapy. , 2009, Molecular aspects of medicine.

[26]  M. Bewley,et al.  Identification and analysis of occludin phosphosites: a combined mass spectrometry and bioinformatics approach. , 2009, Journal of proteome research.

[27]  H. D. de Vries,et al.  Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. , 2008, Free radical biology & medicine.

[28]  D. Praticò Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. , 2008, Trends in pharmacological sciences.

[29]  Xiongwei Zhu,et al.  Antioxidant therapy in Alzheimer's disease: theory and practice. , 2008, Mini reviews in medicinal chemistry.

[30]  Aaron J. Johnson,et al.  Induction of Blood Brain Barrier Tight Junction Protein Alterations by CD8 T Cells , 2008, PloS one.

[31]  Alberto Romagnolo,et al.  Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study , 2008, Journal of Neuroimmunology.

[32]  R. Sutliff,et al.  The Roles of HIV-1 Proteins and Antiretroviral Drug Therapy in HIV-1-Associated Endothelial Dysfunction , 2008, Journal of Investigative Medicine.

[33]  N. Schaeren-Wiemers,et al.  RNA profiling of MS brain tissues. , 2008, International MS journal.

[34]  M. Yano,et al.  Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells , 2008, Journal of NeuroVirology.

[35]  J. Piontek,et al.  Structure and function of claudins. , 2008, Biochimica et biophysica acta.

[36]  T. Kiyota,et al.  Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. , 2008, The American journal of pathology.

[37]  B. Wiesner,et al.  Formation of tight junction: determinants of homophilic interaction between classic claudins , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  R. Gonsette Review: Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? , 2008, Multiple sclerosis.

[39]  M. Toborek,et al.  Limited role of COX-2 in HIV Tat-induced alterations of tight junction protein expression and disruption of the blood–brain barrier , 2007, Brain Research.

[40]  H. D. Vries,et al.  Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology , 2007, Brain Research Reviews.

[41]  Nathalie Arbour,et al.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.

[42]  M. Moss,et al.  Soluble aggregates of the amyloid‐β protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells , 2007, Journal of neurochemistry.

[43]  L. Rivers,et al.  Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis , 2007, Neuroscience.

[44]  J. Newcombe,et al.  Peroxiredoxin V in multiple sclerosis lesions: predominant expression by astrocytes , 2007, Multiple sclerosis.

[45]  M. Eisenstein,et al.  OSP/claudin‐11‐induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179–207 , 2007, European journal of immunology.

[46]  James M. Anderson,et al.  The unique-5 and -6 motifs of ZO-1 regulate tight junction strand localization and scaffolding properties. , 2007, Molecular biology of the cell.

[47]  S. McQuaid,et al.  Persistent endothelial abnormalities and blood–brain barrier leak in primary and secondary progressive multiple sclerosis , 2007, Neuropathology and applied neurobiology.

[48]  S. McQuaid,et al.  Differences in expression of junctional adhesion molecule-A and β-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology , 2007, Acta Neuropathologica.

[49]  D. Vestweber,et al.  Junctional adhesion molecule-a participates in the formation of apico-basal polarity through different domains. , 2006, Experimental cell research.

[50]  Caroline Anderson,et al.  Oxidative stress and therapeutic approaches in HIV dementia. , 2006, Antioxidants & redox signaling.

[51]  R. Musters,et al.  Lipoic Acid Affects Cellular Migration into the Central Nervous System and Stabilizes Blood-Brain Barrier Integrity1 , 2006, The Journal of Immunology.

[52]  S. Butz,et al.  ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability , 2006, The Journal of experimental medicine.

[53]  K. Kaibuchi,et al.  Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). , 2006, Blood.

[54]  H. Edelhauser,et al.  Antibody blockade of junctional adhesion molecule-A in rabbit corneal endothelial tight junctions produces corneal swelling. , 2006, Investigative ophthalmology & visual science.

[55]  R. Jacob,et al.  Vitamins C and E in adolescents and young adults with HIV infection. , 2006, The American journal of clinical nutrition.

[56]  S. Tsukita,et al.  Claudins in occluding junctions of humans and flies. , 2006, Trends in cell biology.

[57]  A. Suzuki,et al.  The PAR-aPKC system: lessons in polarity , 2006, Journal of Cell Science.

[58]  J. Ghersi-Egea,et al.  Brain Protection at the Blood–Cerebrospinal Fluid Interface Involves a Glutathione-Dependent Metabolic Barrier Mechanism , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[59]  J. Greenwood,et al.  Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  J. Firth,et al.  Cadherin-10 is a novel blood–brain barrier adhesion molecule in human and mouse , 2005, Brain Research.

[61]  M. Toborek,et al.  HIV-1 Tat Protein-Induced Alterations of ZO-1 Expression are Mediated by Redox-Regulated ERK1/2 Activation , 2005 .

[62]  B. Engelhardt,et al.  The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. , 2005, Trends in immunology.

[63]  M. Toborek,et al.  Signaling Mechanisms of HIV-1 Tat-Induced Alterations of Claudin-5 Expression in Brain Endothelial Cells , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[64]  L. Fenart,et al.  Mouse syngenic in vitro blood–brain barrier model: a new tool to examine inflammatory events in cerebral endothelium , 2005, Laboratory Investigation.

[65]  P. Grammas,et al.  HIV-1 gp120 Proteins Alter Tight Junction Protein Expression and Brain Endothelial Cell Permeability: Implications for the Pathogenesis of HIV-Associated Dementia , 2005, Journal of neuropathology and experimental neurology.

[66]  M. Ryan,et al.  Occludin: structure, function and regulation. , 2005, Advanced drug delivery reviews.

[67]  C. Teunissen,et al.  Macrophages and neurodegeneration , 2005, Brain Research Reviews.

[68]  B. Engelhardt,et al.  Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact , 2005, Acta Neuropathologica.

[69]  K. Kim,et al.  Hydrogen peroxide-induced alterations of tight junction proteins in bovine brain microvascular endothelial cells. , 2004, Microvascular research.

[70]  C. Carman,et al.  A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them , 2004, The Journal of cell biology.

[71]  S. Butz,et al.  Endothelial adhesion molecule ESAM binds directly to the multidomain adaptor MAGI-1 and recruits it to cell contacts. , 2004, Experimental cell research.

[72]  C. Parkos,et al.  Involvement of the Junctional Adhesion Molecule-1 (JAM1) Homodimer Interface in Regulation of Epithelial Barrier Function* , 2004, Journal of Biological Chemistry.

[73]  A. Prigent-Tessier,et al.  Differential MnSOD and HO-1 expression in cerebral endothelial cells in response to sublethal oxidative stress , 2004, Brain Research.

[74]  R. Nardacci,et al.  Immunohistochemical Localization of Peroxisomal Enzymes During Rat Embryonic Development , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[75]  Elisabetta Dejana,et al.  Endothelial cell–cell junctions: happy together , 2004, Nature Reviews Molecular Cell Biology.

[76]  T. Terasaki,et al.  A pericyte‐derived angiopoietin‐1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie‐2 activation in vitro , 2004, Journal of neurochemistry.

[77]  L. Roccatagliata,et al.  α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis , 2004, Journal of Neuroimmunology.

[78]  B. Engelhardt,et al.  Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts , 2004, Cell and Tissue Research.

[79]  D. Vestweber,et al.  Junctional adhesion molecules (JAMs): more molecules with dual functions? , 2004, Journal of Cell Science.

[80]  D. Dickstein,et al.  Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model , 2003 .

[81]  Alireza Minagar,et al.  Blood-brain barrier disruption in multiple sclerosis , 2003, Multiple sclerosis.

[82]  H. Gendelman,et al.  Mononuclear phagocyte immunity and the neuropathogenesis of HIV‐1 infection , 2003, Journal of leukocyte biology.

[83]  Bernhard Hennig,et al.  HIV‐1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells , 2003, Journal of neuroscience research.

[84]  R. Reynolds,et al.  Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult , 2003, Brain pathology.

[85]  S. McQuaid,et al.  Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood–brain barrier leakage and active demyelination , 2003, The Journal of pathology.

[86]  Yong Woo Lee,et al.  HIV-1 tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain , 2003, Molecular and Cellular Neuroscience.

[87]  A. Vorbrodt,et al.  Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist’s view , 2003, Brain Research Reviews.

[88]  S. Tsukita,et al.  Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.

[89]  Yong Woo Lee,et al.  HIV‐Tat protein induces oxidative and inflammatory pathways in brain endothelium , 2002, Journal of neurochemistry.

[90]  D. Bourdette,et al.  Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis , 2002, Journal of Neuroimmunology.

[91]  P. Annunziata,et al.  Circulating gp120 alters the blood–brain barrier permeability in HIV-1 gp120 transgenic mice , 2002, Neuroscience Letters.

[92]  Hartwig Wolburg,et al.  Tight junctions of the blood-brain barrier: development, composition and regulation. , 2002, Vascular pharmacology.

[93]  B. Kuster,et al.  A Transmembrane Tight Junction Protein Selectively Expressed on Endothelial Cells and Platelets* , 2002, The Journal of Biological Chemistry.

[94]  M. Graves,et al.  Cyclooxygenase-2-positive Macrophages Infiltrate the Alzheimer's Disease Brain and Damage the Blood–brain Barrier Pathology and Laboratory , 2022 .

[95]  S. McQuaid,et al.  Abnormal Endothelial Tight Junctions in Active Lesions and Normal‐appearing White Matter in Multiple Sclerosis , 2002, Brain pathology.

[96]  Tetsuo Noda,et al.  Claudin-based tight junctions are crucial for the mammalian epidermal barrier , 2002, The Journal of cell biology.

[97]  D. Praticò Alzheimer's disease and oxygen radicals: new insights. , 2002, Biochemical pharmacology.

[98]  B. Engelhardt,et al.  Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. , 2002, The Journal of clinical investigation.

[99]  F. Winkler,et al.  X‐ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif , 2001, The EMBO journal.

[100]  M. Itoh,et al.  Junctional adhesion molecule (JAM) binds to PAR-3 , 2001, The Journal of cell biology.

[101]  P. Adamson,et al.  Reactive oxygen species enhance the migration of monocytes across the blood‐brain barrier in vitro , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[102]  B. Engelhardt,et al.  Claudin-1, claudin-2 and claudin-11 are present in tight junctions of choroid plexus epithelium of the mouse , 2001, Neuroscience Letters.

[103]  C. Brosnan,et al.  Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. , 2001, The American journal of pathology.

[104]  Shoichiro Tsukita,et al.  Multifunctional strands in tight junctions , 2001, Nature Reviews Molecular Cell Biology.

[105]  K. Khalili,et al.  Cooperative Interaction between HIV-1 Regulatory Proteins Tat and Vpr Modulates Transcription of the Viral Genome* , 2000, The Journal of Biological Chemistry.

[106]  G. Pendl,et al.  Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. , 2000, The Journal of biological chemistry.

[107]  S. Liebner,et al.  Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme , 2000, Acta Neuropathologica.

[108]  J. Verhoef,et al.  Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV‐1‐associated dementia , 2000, Neuropathology and applied neurobiology.

[109]  F. Orsenigo,et al.  Interaction of Junctional Adhesion Molecule with the Tight Junction Components ZO-1, Cingulin, and Occludin* , 2000, The Journal of Biological Chemistry.

[110]  H. Wolburg,et al.  Tight Junctions of the Blood–Brain Barrier , 2000, Cellular and Molecular Neurobiology.

[111]  C. Patlak,et al.  In Vitro Evidence That β‐Amyloid Peptide 1–40 Diffuses Across the Blood–Brain Barrier and Affects Its Permeability , 2000, Journal of neuropathology and experimental neurology.

[112]  C. Achim,et al.  Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. , 1999, The American journal of pathology.

[113]  S. Tsukita,et al.  Manner of Interaction of Heterogeneous Claudin Species within and between Tight Junction Strands , 1999, The Journal of cell biology.

[114]  S. Tsukita,et al.  Endothelial Claudin , 1999, The Journal of cell biology.

[115]  M. Itoh,et al.  Structural and signalling molecules come together at tight junctions. , 1999, Current opinion in cell biology.

[116]  M. Corada,et al.  Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[117]  S. Tsukita,et al.  Occludin and claudins in tight-junction strands: leading or supporting players? , 1999, Trends in cell biology.

[118]  G. Ellison,et al.  A humoral response to oligodendrocyte-specific protein in MS , 1999, Neurology.

[119]  S. Bamforth,et al.  A dominant mutant of occludin disrupts tight junction structure and function. , 1999, Journal of cell science.

[120]  K. Fujimoto,et al.  Claudin-11/OSP-based Tight Junctions of Myelin Sheaths in Brain and Sertoli Cells in Testis , 1999, The Journal of cell biology.

[121]  B. Engelhardt,et al.  Ultrastructural localization of adhesion molecules in the healthy , 1999, Cell and Tissue Research.

[122]  S. Croul,et al.  Molecular pathway involved in HIV‐1‐induced CNS pathology: role of viral regulatory protein, Tat , 1999, Journal of leukocyte biology.

[123]  R Kemler,et al.  Cadherins and tissue formation: integrating adhesion and signaling , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[124]  K. Fujimoto,et al.  Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[125]  D. Roos,et al.  Reactive oxygen species are required for the phagocytosis of myelin by macrophages , 1998, Journal of Neuroimmunology.

[126]  K. Fujimoto,et al.  A Single Gene Product, Claudin-1 or -2, Reconstitutes Tight Junction Strands and Recruits Occludin in Fibroblasts , 1998, The Journal of cell biology.

[127]  R. Schmidt,et al.  Peroxynitrite formation within the central nervous system in active multiple sclerosis , 1998, Journal of Neuroimmunology.

[128]  E. Dejana,et al.  Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration , 1998, The Journal of cell biology.

[129]  V. Perry,et al.  Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood–brain barrier breakdown in vivo , 1998, Neuroscience.

[130]  M. Smith,et al.  Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. , 1998, The American journal of pathology.

[131]  M. Freedman,et al.  Increased Peroxidation and Reduced Antioxidant Enzyme Activity in Alzheimer's Disease , 1998, Experimental Neurology.

[132]  L. Rubin,et al.  Occludin as a possible determinant of tight junction permeability in endothelial cells. , 1997, Journal of cell science.

[133]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[134]  D. Hinton,et al.  Extensive peroxynitrite activity during progressive stages of central nervous system inflammation , 1997, Journal of Neuroimmunology.

[135]  J. Inazawa,et al.  Mammalian occludin in epithelial cells: its expression and subcellular distribution. , 1997, European journal of cell biology.

[136]  V. Perry,et al.  Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. , 1997, Brain : a journal of neurology.

[137]  C. Patlak,et al.  Fate of Cerebrospinal Fluid‐Borne Amyloid β‐Peptide: Rapid Clearance into Blood and Appreciable Accumulation by Cerebral Arteries , 1996, Journal of neurochemistry.

[138]  B. Engelhardt,et al.  ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. , 1996, The American journal of pathology.

[139]  F. Breviario,et al.  Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. , 1996, Blood.

[140]  Luz Claudio,et al.  Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients , 1995, Acta Neuropathologica.

[141]  M. Dehouck,et al.  Hypoxia Increases the Susceptibility to Oxidant Stress and the Permeability of the Blood‐Brain Barrier Endothelial Cell Monolayer , 1995, Journal of neurochemistry.

[142]  D. Butterfield,et al.  Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.

[143]  W. Pardridge,et al.  Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[144]  G. W. Pace,et al.  The role of oxidative stress in HIV disease. , 1995, Free radical biology & medicine.

[145]  W. D. Ehmann,et al.  Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.

[146]  P. Hedera,et al.  Differential degeneration of the cerebral microvasculature in Alzheimer's disease. , 1995, Neuroreport.

[147]  M. Dohadwala,et al.  Exogenous tat protein activates central nervous system-derived endothelial cells , 1994, Journal of Neuroimmunology.

[148]  A. Favier,et al.  Antioxidant status and lipid peroxidation in patients infected with HIV. , 1994, Chemico-biological interactions.

[149]  W. Risau,et al.  Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. , 1994, Journal of cell science.

[150]  B. Zlokovic,et al.  Blood-brain barrier transport of circulating Alzheimer's amyloid beta. , 1993, Biochemical and biophysical research communications.

[151]  M. Itoh,et al.  Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.

[152]  J. Firth,et al.  Immunohistochemical localization of adherens junction components in blood-brain barrier microvessels of the rat. , 1993, Journal of cell science.

[153]  B E Kendall,et al.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.

[154]  N J Abbott,et al.  Electrical resistance across the blood‐brain barrier in anaesthetized rats: a developmental study. , 1990, The Journal of physiology.

[155]  R. Crystal,et al.  SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS , 1989, The Lancet.

[156]  F. Zemlan,et al.  Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation , 1989, Brain Research.

[157]  H. Wolburg,et al.  Freeze-fracture analysis of endothelial cell membranes in rabbit carotid arteries subjected to short-term atherogenic stimuli , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[158]  I Hüttner,et al.  Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[159]  S. Olesen,et al.  Electrical resistance of brain microvascular endothelium , 1982, Brain Research.

[160]  Hartwig Wolburg,et al.  Choroid plexus: biology and pathology , 2009, Acta Neuropathologica.

[161]  E. Peterhans Reactive oxygen species and nitric oxide in viral diseases , 2007, Biological Trace Element Research.

[162]  Shailendra Giri,et al.  GSNO attenuates EAE disease by S‐nitrosylation‐mediated modulation of endothelial‐monocyte interactions , 2007, Glia.

[163]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[164]  B. Engelhardt,et al.  The Blood-Brain Barrier in EAE , 2005 .

[165]  H. Wolburg,et al.  Involvement of the choroid plexus in central nervous system inflammation , 2001, Microscopy research and technique.

[166]  G. Comi,et al.  Immunological markers in multiple sclerosis , 2000, Neurological Sciences.

[167]  W R Markesbery,et al.  Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.

[168]  H. McFarland,et al.  Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. , 1995, Critical reviews in clinical laboratory sciences.